Magnetic resonance spectroscopy in the evaluation of treatment efficacy in unipolar major depressive disorder: A review of the literature

Functional Neurology

Volumn 27, Issue 1, 2012, Pages 13-22

  Caverzasi, Eduardo ^a,b   Pichiecchio, Anna ^a,b   Poloni, Guy Umberto ^a,b   Calligaro, Alessandro ^b,c   Pasin, Moreno ^a,b   Palesi, Fulvia ^a,b   Castellazzi, Gloria ^a,b   Pasquini, Massimo ^b   Biondi, Massimo ^b   Barale, Francesco ^b,c   Bastianello, Stefano ^a,b  

^a C MONDINO NATIONAL NEUROLOGICAL INSTITUTE   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

1H MRS; ECT; Major depression disorder; MRI; Pharmacological therapy; Psychiatric disorders; Spectroscopy

Indexed keywords

4 AMINOBUTYRIC ACID; ANTIDEPRESSANT AGENT; CHOLINE; CITALOPRAM; FLUOXETINE; GLUTAMIC ACID; N ACETYLASPARTIC ACID; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; VENLAFAXINE;

AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; ARTICLE; CAUDATE NUCLEUS; CINGULATE GYRUS; COGNITIVE THERAPY; ELECTROCONVULSIVE THERAPY; FRONTAL CORTEX; HIPPOCAMPUS; HUMAN; MAJOR DEPRESSION; MEDLINE; NEUROTRANSMISSION; OCCIPITAL CORTEX; ORBITAL CORTEX; PARAHIPPOCAMPAL GYRUS; PHARMACEUTICAL CARE; PONS; PREFRONTAL CORTEX; PROTON NUCLEAR MAGNETIC RESONANCE; PUTAMEN; SLEEP DEPRIVATION; SYSTEMATIC REVIEW; THALAMUS; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANTIDEPRESSIVE AGENTS; BRAIN; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; DRUG MONITORING; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 84862607216     PISSN: 03935264     EISSN: 19713274     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Eliassen JC, Boespflug EL, Lamy M, Allendorfer J, Chu WJ, Szaflarski JP. Brain-mapping techniques for evaluating poststroke recovery and rehabilitation: a review. Top Stroke Rehabil 2008;15:427-450
2. Griffith HR, Stewart CC, den Hollander JA. Proton magnetic resonance spectroscopy in dementias and mild cognitive impairment. Int Rev Neurobiol 2009;84:105-31
3. Law M. Advanced imaging techniques in brain tumors. Cancer Imaging 9 Spec No A:S4-9, 2009
4. Charles HC, Lazeyras F, Krishnan KR, Boyko OB, Payne M, Moore D. Brain choline in depression: in vivo detection of potential pharmacodynamic effects of antidepressant therapy using hydrogen localized spectroscopy. Prog Neuropsychopharmacol Biol Psychiatry 1994;18:1121-1127
5. Sonawalla SB, Renshaw PF, Moore CM et al. Compounds containing cytosolic choline in the basal ganglia: a potential biological marker of true drug response to fluoxetine. Am J Psychiatry 1999;156:1638-1640
6. Ende G, Braus DF, Walter S, Weber-Fahr W, Henn FA. The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study. Arch Gen Psychiatry 2000;57:937-943
7. Sanacora G, Mason GF, Rothman DL, Krystal JH. Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry 2002;159:663-665
8. Sanacora G, Mason GF, Rothman DL et al. Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry 2003;160:577-579
9. Pfleiderer B, Michael N, Erfurth A et al. Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Res 2003;122:185-192
10. Obergriesser T, Ende G, Braus DF, Henn FA. Long-term follow-up of magnetic resonance-detectable choline signal changes in the hippocampus of patients treated with electroconvulsive therapy. J Clin Psychiatry 2003;64:775-780
11. Michael N, Erfurth A, Ohrmann P, Arolt V, Heindel W, Pfleiderer B. Neurotrophic effects of electroconvulsive therapy: a proton magnetic resonance study of the left amygdalar region in patients with treatment-resistant depression. Neuropsychopharmacology 2003;28:720-725
12. Michael N, Erfurth A, Ohrmann P, Arolt V, Heindel W, Pfleiderer B. Metabolic changes within the left dorsolateral prefrontal cortex occurring with electroconvulsive therapy in patients with treatment resistant unipolar depression. Psychol Med 2003;33:1277-1284
13. Sanacora G, Fenton LR, Fasula MK et al. Cortical gammaaminobutyric acid concentrations in depressed patients receiving cognitive behavioral therapy. Biol Psychiatry 2006; 59:284-286
14. Gonul AS, Kitis O, Ozan E et al. The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:120-125
15. Luborzewski A, Schubert F, Seifert F et al. Metabolic alterations in the dorsolateral prefrontal cortex after treatment with high-frequency repetitive transcranial magnetic stimulation in patients with unipolar major depression. J Psychiatr Res 2007;41:606-615
16. Murck H, Schubert MI, Schmid D, Schussler P, Steiger A, Auer DP. The glutamatergic system and its relation to the clinical effect of therapeutic-sleep deprivation in depression-an MR spectroscopy study. J Psychiatr Res 2009;43:175-180
17. Block W, Traber F, von Widdern O et al. Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder: correlates and predictors of treatment response. Int J Neuropsychopharmacol 2009; 12:415-422
18. Bernier D, Barthxa R, Devarajan S, Macmaster FP, Schmidt MH, Rusak B. Effects of overnight sleep restriction on brain chemistry and mood in women with unipolar depression and healthy controls. J Psychiatry Neurosci 2009;34:352-360
19. Caverzasi E, Pichiecchio A, Calligaro A et al. Complications in major depressive disorder therapy: a review of magnetic resonance spectroscopy studies. Funct Neurol 2008;23:129-132
20. Janowsky DS, el-Yousef MK, Davis J-M, Sekerke HJ. A cholinergic-adrenergic hypothesis of mania and depression. Lancet 1972;2:632-635
21. Renshaw PF, Lafer B, Babb SM et al. Basal ganglia choline levels in depression and response to fluoxetine treatment: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 1997;41:837-843
22. Petroff OA. Biological 1H NMR spectroscopy. Comp Biochem Physiol B 1988;90:249-260
23. Frahm J, Bruhn H, Gyngell ML, Merboldt KD, Hänicke W, Sauter R. Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med 1989;9:79-93
24. Klein J, Gonzalez R, Köppen A, Löffelholz K. Free choline and choline metabolites in rat brain and body fluids: sensitive determination and implications for choline supply to the brain. Neurochem Int 1993;22:293-300
25. Ende G, Demirakca T, Tost H. The biochemistry of dysfunctional emotions: proton MR spectroscopic findings in major depressive disorder. Prog Brain Res 2006;156: 481-501
26. Dougherty DD, Rauch SL. Brain correlates of antidepressant treatment outcome from neuroimaging studies in depression. Psychiatr Clin North Am 2007;30:91-103
27. Brambilla P, Perez J, Barale F, Schettini G, Soares JC. GABAergic dysfunction in mood disorders. Mol Psychiatry 2003;8:721-737
28. Behar KL, Rothman DL, Petersen KF et al. Preliminary evidence of reduced cortical GABA levels in localized 1HNMR spectra of alcohol dependent and hepatic encephalopathy patients. Am J Psychiatry 1999;156:952-954
29. Rothman DL, Petroff OA, Behar KL, Mattson RH. Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo. Proc Natl Acad Sci USA 1993; 90:5662-5666
30. Sanacora G, Mason GF, Rothman DL et al. Reduced cortical 3-aminobutyric acid levels in depressed patients by proton magnetic spectroscopy. Arch Gen Psychiatry 1999;56:1043-1047
31. Bhagwagar Z, Wylezinska M, Taylor M, Jezzard P, Matthews PM, Cowen PJ. Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. Am J Psychiatry 2004;161:368-370
32. Bettendorff L, Sallanon-Moulin M, Touret M, Wins P, Margineanu I, Schoffeniels E. Paradoxical sleep deprivation increases the content of glutamate and glutamine in rat cerebral cortex. Sleep 1996;19:65-71
33. Hasler G, Neumeister A, van der Veen JW et al. Normal prefrontal gamma-aminobutyric acid levels in remitted depressed subjects determined by proton magnetic resonance spectroscopy. Biol Psychiatry 2005;58:969-973
34. Hasler G, van der Veen JW, Tumonis T, Meyers N, Shen J, Drevets WC. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 2007;64:193-200
35. Kimbrell TA, Little JT, Dunn RT et al. Frequency dependence of antidepressant response to left prefrontal repetitive transcranial magnetic stimulation (rTMS) as a function of baseline cerebral glucose metabolism. Biol Psychiatry 1999;46:1603-1613
36. Eschweiler GW, Wegerer C, Schlotter W et al. Left prefrontal activation predicts therapeutic effects of repetitive transcranial magnetic stimulation (rTMS) in major depression. Psychiatry Res 2000;99:161-172
37. Altshuler LL, Bartzokis G, Grieder T, Curran J, Mintz J. Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: an MRI study demonstrating neuroantomic specificity. Arch Gen Psychiatry 1998; 55:663-664
38. Sheline YI, Gado MH, Price JL. Amygdala core nuclei volumes are decreased in recurrent major depression. Neuroreport 1998;9:2436-2441
39. Drevets WC. Prefrontal cortical-amygdalar metabolism in major depression. Ann N Y Acad Sci 1999;877:614-637
40. LeDoux JE: Emotion circuits in the brain. Annu Rev Neurosci 2000;23:155-184
41. Davis M, Whalen PJ. The amygdala: vigilance and emotion. Mol Psychiatry 2001;6:13-34
42. Sheline YI, Sanghavi M, Mintun MA, Gado MH. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J Neurosci 1999;19:5034-5043
43. Ashtari M, Greenwald BS, Kramer-Ginsberg E et al. Hippocampal/amygdala volumes in geriatric depression. Psychol Med 1999;29:629-638
44. Vaidya VA, Siuciak JA, Du F, Duman RS. Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures. Neuroscience 1999;89:157-166
45. Madsen TM, Treschow A, Bengzon J, Bolwig TG, Lindvall O, Tingström A. Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry 2000;47:1043-1049
46. Gombos Z, Spiller A, Cottrell GA, Racine RJ, McIntyre Burnham W. Mossy fiber sprouting induced by repeated electroconvulsive shock seizures. Brain Res 1999;844:28-33
47. Duman RS, Vaidya VA. Molecular and cellular actions of chronic electroconvulsive seizures. J ECT 1998;14:181-193
48. Drevets WC, Price JL, Simpson JR et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature 1997;386:824-827
49. Taylor SM. Electroconvulsive therapy, brain-derived neurotrophic factor, and possible neurorestorative benefit of the clinical application of electroconvulsive therapy. J ECT 2008;24:160-165